A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer

被引：2
|
作者：
Kasi, P. M. [1 ]
Sawyer, S. [2 ]
Guilford, J. [2 ]
Munro, M. [2 ]
Ellers, S. [2 ]
Hook, N. [2 ]
Krinshpun, S. [2 ]
Moshkevich, S. [2 ]
Billings, P. R. [2 ]
Aleshin, A. [2 ]
机构：
[1] Univ Iowa Hlth Care, Internal Med, Iowa City, IA USA
[2] Natera Inc, Oncol, San Carlos, CA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.630
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
520TiP
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [31] Impact of a metastatic site on circulating tumor DNA analysis in patients with metastatic colorectal cancer
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    CANCER SCIENCE, 2022, 113 : 823 - 823
  • [32] Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis
    Messaritakis, Ippokratis
    Koulouris, Andreas
    Boukla, Eleni
    Vogiatzoglou, Konstantinos
    Lagkouvardos, Ilias
    Intze, Evangelia
    Sfakianaki, Maria
    Chondrozoumaki, Maria
    Karagianni, Michaela
    Athanasakis, Elias
    Xynos, Evangelos
    Tsiaoussis, John
    Christodoulakis, Manousos
    Flamourakis, Matthaios E.
    Tsagkataki, Eleni S.
    Giannikaki, Linda
    Chliara, Evdoxia
    Mavroudis, Dimitrios
    Tzardi, Maria
    Souglakos, John
    CANCERS, 2024, 16 (10)
  • [33] CORRECT-MRD I: A clinical validation study to predict recurrence in stage II-III colorectal cancer (CRC) using a bespoke circulating tumor DNA (ctDNA) assay to detect molecular residual disease (MRD).
    Tsukada, Yuichiro
    Sagawa, Tamotsu
    Srinivasan, Gopalakrishnan
    Hubert, Ayala
    Purim, Ofer
    Semenisty, Valeriya
    Lo, Nangi
    Mondello, Giuseppe
    Gracian, Antonio Cubillo
    Marti, Tara
    Subramaniam, Somasundaram
    Palomares, Melanie R.
    Baehner, Frederick
    de Jong, Floris A.
    Kerr, David James
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : TPS98 - TPS98
  • [34] Evaluation of circulating tumor cells in stage III colorectal cancer patients under three or six months of adjuvant therapy.
    Messaritakis, Ippokratis
    Koulouridi, Asimina
    Sfakianaki, Maria
    Vogiatzoglou, Konstantinos
    Gouvas, Nikolaos
    Tsiaousis, Ioannis
    Athanasakis, Elias
    Xynos, Evangelos
    Sougklakos, Ioannis
    Boukovinas, Ioannis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15601 - E15601
  • [35] Screening for Defective DNA Mismatch Repair in Stage II and III Colorectal Cancer Patients
    Chai, Siaw Ming
    Zeps, Nik
    Shearwood, Anne-Marie
    Grieu, Fabienne
    Charles, Adrian
    Harvey, Jennet
    Goldblatt, Jack
    Joseph, David
    Iacopetta, Barry
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (11) : 1017 - 1025
  • [36] Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer
    Zhao, Zhengyi
    Cai, Shangli
    Wang, Zhijie
    JAMA ONCOLOGY, 2020, 6 (06) : 932 - 932
  • [37] Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
    Yang, Ying-Chi
    Wang, Dong
    Jin, Lan
    Yao, Hong-Wei
    Zhang, Jing-Hui
    Wang, Jin
    Zhao, Xiao-Mu
    Shen, Chun-Ying
    Chen, Wei
    Wang, Xue-Liang
    Shi, Rong
    Chen, Si-Yi
    Zhang, Zhong-Tao
    BIOSCIENCE REPORTS, 2018, 38
  • [38] Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection
    Yu, Jun-Hui
    Wang, Dong
    Jin, Lan
    Wang, Jin
    Zhao, Xiao-Mu
    Wu, Guo-Cong
    Yao, Hong-Wei
    Yang, Ying-Chi
    Zhang, Zhong-Tao
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1487 - 1494
  • [39] Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study
    Noemi Garrigós
    Javier Gallego
    Carmen Guillén-Ponce
    Patricia Guaraz
    Miriam García-Bautista
    Adela Castillejo
    Ángeles Gómez-Martínez
    Alfredo Carrato
    Álvaro Rodríguez-Lescure
    José L. Soto
    Clinical and Translational Oncology, 2010, 12 : 142 - 147
  • [40] Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study
    Garrigos, Noemi
    Gallego, Javier
    Guillen-Ponce, Carmen
    Guaraz, Patricia
    Garcia-Bautista, Miriam
    Castillejo, Adela
    Gomez-Martinez, Angeles
    Carrato, Alfredo
    Rodriguez-Lescure, Alvaro
    Soto, Jose L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (02): : 142 - 147
12345